A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.

T, Kimura; K, Kozuma; K, Tanabe; S, Nakamura; M, Yamane; T, Muramatsu; S, Saito; J, Yajima; N, Hagiwara; K, Mitsudo; JJ, Popma; PW, Serruys; Y, Onuma; S, Ying; S, Cao; P, Staehr; WF, Cheong; H, Kusano; GW, Stone

doi:10.1093/eurheartj/ehv435

Public

A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.

Shared by NobleBlocks on Sep 1, 2015 • 12:00 AM UTC

Authors:

Kimura T

Kozuma K

Tanabe K

Abstract

<h4>Aims</h4>Theoretically, bioresorbable vascular scaffolds (BVSs) may provide superior long-term results compared with permanent metallic drug-eluting stents (DESs). However, whether BVSs are as safe and effective as metallic DESs prior to complete bioresorption is unknown.<h4>Methods and results<...

Subject

Thrombosis

Restenosis

Coronary Stent

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!